Business
Press Release Jan 30 2025
Natco Pharma Limited has informed the Exchange regarding a press release dated January 30, 2025, titled "NATCO announces approval of its ANDA for Everolimus tablets".
About this update from Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated January 30, 2025, titled "NATCO announces approval of its ANDA for Everolimus tablets". View Attachment
View stock analysis, news, and events for Natco Pharma Limited